Effect of memantine, an anti-Alzheimer’s drug, on rodent microglial cells in vitro
Abstract The pathophysiology of Alzheimer’s disease (AD) is related to neuroinflammatory responses mediated by microglia. Memantine, an antagonist of N-methyl-d-aspartate (NMDA) receptors used as an anti-Alzheimer’s drug, protects from neuronal death accompanied by suppression of proliferation and a...
Guardado en:
Autores principales: | Toru Murakawa-Hirachi, Yoshito Mizoguchi, Masahiro Ohgidani, Yoshinori Haraguchi, Akira Monji |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e57add55b48d470384d5902b47f71443 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Update on the use of memantine in Alzheimer’s disease
por: Robert J van Marum
Publicado: (2009) -
Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands
por: Hoogveldt B, et al.
Publicado: (2011) -
The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis
por: Kishi T, et al.
Publicado: (2017) -
Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial.
por: Chris Fox, et al.
Publicado: (2012) -
Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer’s disease
por: Umamon Puangthong, et al.
Publicado: (2009)